← Every company
Amgen Inc SEC Filings
What Amgen Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
AMGN overview →Filings on file
143
since Oct 14, 2016
Warning signs
1
latest Jul 31, 2026
Last results
Aug 4, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Oct 6, 2023 | Acquisition or sale completedNew debt 8-K | Read ↗ |
| Apr 16, 2021 | Acquisition or sale completed 8-K | Read ↗ |
| Mar 18, 2021 | Tender offer SC TO-T | Read ↗ |
| Feb 9, 2021 | Merger vote or registration S-4 | Read ↗ |
| Nov 21, 2019 | Acquisition or sale completed 8-K | Read ↗ |
| Feb 5, 2018 | Tender offer SC TO-I | Read ↗ |
| Nov 1, 2016 | Merger vote or registration S-4 | Read ↗ |
Source: Amgen Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on AMGN
Company overviewEverything on AMGN in one place, with the price.Insider tradingWhat AMGN's own officers and directors buy and sell.Executive payWhat AMGN awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in AMGN.Funds holding itWhich funds and ETFs hold AMGN, and how big a bet.LobbyingWhat AMGN spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AMGN's account, and who they worked for.Federal contractsWhat federal agencies pay AMGN.PatentsWhat AMGN is filing at the patent office.